just started semaglutide & Tirzepatide Weight Loss Injections ✨ 3-Month Transformation on Semaglutide!

The primary outcome of this study was the first diagnosis of CRC within 15 years from the initial treatment of GLP-1RAs or non-GLP-1RA diabetes medications (insulin, metformin, alpha-glucosidase inhibitors, dipeptidyl-peptidase-4 inhibitors (DPP-4i), sodium-glucose cotransporter-2 inhibitors (SGLT2i), sulfonylureas (SU), and thiazolidinediones (TZD))

An Innovative Medical Weight Loss Option in Clinton Township GLP-1 Agonist is an exciting new FDA-approved medication that helps patients achieve significant weight loss through a weekly injection

SanMiguel N, Pardo M, Carratal-Ros C, Lpez-Cruz L, Salamone JD, Correa M

Consequently, the improvements could have been due to a placebo effect (9)